A Phase 1, Placebo-controlled, Randomized, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of An Adjuvanted Clostridium Difficile Vaccine Administered As A 3-dose Regimen In Healthy Adults Aged 50 To 85 Years

Trial Profile

A Phase 1, Placebo-controlled, Randomized, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of An Adjuvanted Clostridium Difficile Vaccine Administered As A 3-dose Regimen In Healthy Adults Aged 50 To 85 Years

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs PF 6425090 (Primary)
  • Indications Clostridium infections
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Jun 2015 Planned End Date changed from 1 Jul 2015 to 1 May 2015 as per ClinicalTrials.gov record.
    • 09 Jun 2015 Planned primary completion date changed from 1 Jul 2015 to 1 May 2015 as per ClinicalTrials.gov record.
    • 09 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top